Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma

Pathobiology

Volumn 71, Issue 2, 2004, Pages 84-92

  Kase, Satoru ^a   Osaki, Mitsuhiko ^a,b,c   Honjo, Soichiro ^a   Hashimoto, Kiyoshi ^a   Adachi, Hironobu ^a   Tsujitani, Shunichi ^c   Ito, Hisao ^a  

^a Faculty of Medicine   (Japan)

^b GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

Carcinoma; Cyclooxygenase; Dysplasia; Esophagus

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0346963271     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074421     Document Type: Article

References (56)

1. Dempke W, Rie C, Grothey A, Schmoll HJ: Cyclooxygenase-2: A novel target for cancer chemotherapy? J Cancer Res Clin Oncol 2001; 127:411-417.
2. DeWitt DL: Prostaglandin endoperoxyde synthase: Regulation of enzyme expression. Biochim Biophys Acta 1991;1083:121-134.
3. O'Neil GP, Ford-Hutchinson AW: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993; 330:156-160.
4. Kangman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA, Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-2559.
5. Herschman HR: Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125-140.
6. Kujubu DA, Reddy ST, Fletcher BS, Herschman HR: Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem 1993;268:5425-5430.
7. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, O'Neil G: Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996; 111:445-454.
8. Vane J: Towards a better aspirin. Nature 1994; 367:215-216.
9. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-1280.
10. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-3789.
11. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-1188.
12. Kargman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA, Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-2559.
13. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM: Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 1996;93:4816-4820.
14. Brannon TS, North AJ, Wells LB, Shaul PW: Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 1994;93:2230-2235.
15. Smith CJ, Morrow JD, Roberts LJd and Marnett LJ: Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun 1993;192: 787-793.
16. Bryant CE, Appleton I, Mitchell JA: Vascular endothelial growth factor up-regulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells. Life Sci 1998;62: 2195-2201.
17. 2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res 2000;41:873-881.
18. Bauer AK, Dwy-Nield LD, Malkinson AM: High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis (Lond) 2000;21:543-550.
19. Hwang D, Scollard D, Byrne J and Levine E: Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455-460.
20. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN: Cyclooxygenase-1 is upregulated in cervical carcinomas: Autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002;62:424-432.
21. Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS: Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and non small cell lung carcinoma. Cancer 2002;94:1023-1031.
22. Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu X, Levine AC: Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 2000;56:671-676.
23. Thum MJ: NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 1996;25:333-348.
24. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-614.
25. Meade EA, Smith WL, DeWitt DL: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-6614.
26. Robert A: Antisecretory, antiulcer, cytoprotection and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res 1976;2:507-520.
27. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K: Expression and selective inhibitor of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995;305:479-484.
28. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr: Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-1327.
29. Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116-1119.
30. Farrow DC, Vaughan TL, Hansen PD, Stan-ford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
31. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
32. Schottenfeld D: Epidemiology of cancer of esophagus. Semin Oncol 1984;11:92-100.
33. Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, Gabbert HE: Basaloid squamous cell carcinoma of the esophagus: Diagnosis and prognosis. Cancer 1997;79: 1871-1878.
34. Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ: Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000;60:5767-5772.
35. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schrör K: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204.
36. Ratnasinghe D, Tangrea J, Roth MJ, Dawsey S, Hu N, Anver M, Wang QH, Taylor PR: Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus: an immunohistochemical survey. Anticancer Res 1999;19: 171-174.
37. Kawabe A, Shimada Y, Uchida S, Maeda M, Sato F, Itami A, Imamura M: Expression of cyclooxygenase-2 is associated with carcinogenesis of the lowerpart of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 2002;62:46-54.
38. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M: Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000;6:1229-1238.
39. Nagamatsu M, Mori M, Kuwano H, Sugimachi K, Akiyoshi T: Serial histologic investigation of squamous epithalial dysplasia associated with carcinoma of the esophagus. Cancer 1992;69: 1094-1098.
40. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T: Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993;119:441-449.
41. Watanabe H, Jass JR, Sobin LH: World Health Organization. International Histological Classification of the Tumors; Histological Typing of Esophageal and Gastric Tumors, ed 2. Berlin, Springer, 1992.
42. Sobin LH, Wittekind Ch: UICC TNM classification of malignant tumors, ed 5. New York, Wiley, 1997.
43. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
44. Wolft H, Saukknen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58:4997-5001.
45. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998;58:3761-3764.
46. Watkins DN, Peroni DJ, Lenzo JC, Knight DA, Garlepp MJ, Thompson PJ: Expression and localization of Cox-2 in human airways and cultured airway epithelial cells. Eur Respir J 1999;13:999-1007.
47. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC, Langenbach R: Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 2002;62:3395-3401.
48. 2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289-293.
49. Tsujii M, DuBois RN: Alteration in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endoperoxyde synthase 2. Cell 1995;83:493-501.
50. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996;87:803-809.
51. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM: Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999;18: 5931-5942.
52. Bamba H, Ota S, Kato A, Adachi A, Itoyama S, Matsuzaki F: High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 1999;83:470-475.
53. Hull MA, Booth JK, Tisbury A, Scott N, Bonifer C, Markham AF, Coletta PL: Cyclooxygenase 2 is upregulated and localized to macrophages in the intestine of Min mice. Br J Cancer 1999;79:1399-1405.
54. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL, Hull MA: Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000;156:545-553.
55. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN: Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10 (-/-) mice. Gastroenterology 2000;118:337-345.
56. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drug. Nat New Biol 1971;231:232-235.